Delivery Order SPE2DB22D2005-SPE2DB24FJHL7

Award Date 2/7/24
Potential Completion Date 2/8/24
Potential Value $3.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,623.71 Firm Fixed Price Delivery Order is for the provision of 100 units of the drug Nitrofurantoin Mono-MCR 100 mg. The contract has an ultimate completion date of January 23, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of 100 units of Nitrofurantoin Mono-MCR 100 mg medication, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,337.94 and is a Firm Fixed Price Delivery Order with an ultimate completion date of January 23, 2024. The contract is not designated with any set-aside requirements, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $2,349.94 and is a Firm Fixed Price Delivery Order. The contract is for the delivery of Nitrofurantoin Mono-MCR 100 mg, a pharmaceutical product, to support military treatment facilities and veterans' healthcare programs. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, with a ceiling value of $3,993.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,561,934,902 units of the pharmaceutical product Nitrofurantoin Mono-MCR 100 mg. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of August 25, 2023. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,106.37, is for the delivery of 4567670792 NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 25, 2025. It is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,960,849 units of the pharmaceutical product Nitrofurantoin Mono-MCR 100 MG. The $1,531.01 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,962.11 firm fixed-price delivery order is for the supply of 4,566,995,841 units of NITROFURANTOIN MONO-MCR 100 MG 1000S, a generic pharmaceutical product. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $1,624.72 firm fixed-price delivery order is for the supply of Nitrofurantoin Mono-MCR 100 mg medication, with a period of performance through July 9, 2024. The award is not associated with any set-aside designation. It is one of several federal contracts and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $6,808.96, is for the delivery of 240 ml bottles of the drug Nitrofurantoin 25 mg/5 ml suspension. This is a firm fixed-price delivery order contract with an ultimate completion date of March 1, 2022. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a significant vendor for the DLA and...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense, to the Amerisourcebergen Drug Corp's Corporate Office Division. The $1,003.54 firm-fixed-price delivery order is for the provision of Nitrofurantoin Mono-MCR 100 mg medication, a common antibiotic drug. The award is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the primary vehicle for...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJHL7
    Delivery Order

This federal contract award, identified as SPE2DB22D2005|SPE2DB24FJHL7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,705.71, is for the delivery of Nitrofurantoin Mono-MCR 100 mg 1000s, a pharmaceutical product. The contract has a fixed-price delivery order type with a completion date of February 8, 2024.

Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in the System for Award Management (SAM.gov). The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.

Generated 5/14/25, 9:56 AM